These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37032940)

  • 21. Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy.
    Medda P; Toni C; Luchini F; Giorgi Mariani M; Mauri M; Perugi G
    Bipolar Disord; 2015 Dec; 17(8):892-901. PubMed ID: 26643014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Atypical Neuroleptic Malignant Syndrome After Treatment of Cocaine Intoxication: A Case Report and Literature Review.
    Miller M; Zezetko A; Satodiya R
    Cureus; 2023 Feb; 15(2):e35538. PubMed ID: 37007397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catatonia after cerebral hypoxia: do the usual treatments apply?
    Quinn DK; Abbott CC
    Psychosomatics; 2014; 55(6):525-35. PubMed ID: 25262046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
    Velosa A; Neves A; Barahona-Corrêa JB; Oliveira-Maia AJ
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31213433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral and Intranasal Ketamine Use in Treatment-Resistant Catatonia: A Clinical Case Report.
    Gregor EA; Zheng W
    Am J Case Rep; 2023 Apr; 24():e939530. PubMed ID: 37095688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series.
    Ghaziuddin N; Hendriks M; Patel P; Wachtel LE; Dhossche DM
    J Child Adolesc Psychopharmacol; 2017 May; 27(4):359-365. PubMed ID: 28398818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.
    Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C
    Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic Malignant Syndrome Status Post Anoxic Brain Injury: A Case Presentation of Heightened Susceptibility in the Brain Injury Population.
    Cocuzzo B; Fisher KA; Alvarez Villalba CL
    Cureus; 2023 Mar; 15(3):e35740. PubMed ID: 37025743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome].
    Hirjak D; Sartorius A; Kubera KM; Wolf RC
    Nervenarzt; 2019 Jan; 90(1):12-24. PubMed ID: 30128733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report.
    Nomura K; Sakawaki S; Sakawaki E; Yamaoka A; Aisaka W; Okamoto H; Takeyama Y; Uemura S; Narimatsu E
    Medicine (Baltimore); 2021 May; 100(19):e25967. PubMed ID: 34106671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Severe Neuroleptic Malignant Syndrome Treated with Daily Electroconvulsive Therapy: A Case Report.
    Aki ÖE; Gürcan A; Gürel ŞC; Yazici MK
    Turk Psikiyatri Derg; 2022; 33(2):139-142. PubMed ID: 35730514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute catatonia and neuroleptic malignant syndrome. A case of infantile psychosis].
    Revuelta E; Bordet R; Piquet T; Ghawche F; Destee A; Goudemand M
    Encephale; 1994; 20(3):351-4. PubMed ID: 7916282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A Case Series.
    Morcos N; Rosinski A; Maixner DF
    J ECT; 2019 Dec; 35(4):225-230. PubMed ID: 31764444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual catatonic state following neuroleptic malignant syndrome.
    Caroff SN; Mann SC; Keck PE; Francis A
    J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report.
    Tsai MC; Huang TL
    Chang Gung Med J; 2010; 33(5):576-80. PubMed ID: 20979709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ECT in the treatment of the catatonic syndrome.
    Rohland BM; Carroll BT; Jacoby RG
    J Affect Disord; 1993 Dec; 29(4):255-61. PubMed ID: 8126312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant catatonia-induced respiratory failure with response to ECT.
    Boyarsky BK; Fuller M; Early T
    J ECT; 1999 Sep; 15(3):232-6. PubMed ID: 10492863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome.
    White DA; Robins AH
    CNS Spectr; 2000 Jul; 5(7):58-65. PubMed ID: 18197157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.